Back to All Events

Mastermind: Tim Knotnerus (Agomab): Learnings from Agomab's recent $208 mio NASDAQ IPO

MASTERMIND is an opportunity for informal CEO peer-to-peer conversations. 

Each MASTERMIND is anchored by a member willing to share and discuss a particular experience / expertise. 

Previous
12 May

INSIGHTS: Jennifer Garvey Berger (Cultivating Leadership): Unlocking Leadership Mindtraps
Next
20 May

Mastermind: Mihriban Tuna (Immutrin) / Tom Goodman (Cooley LLP): Learnings from Immutrin's $87m Series A investment